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Cardiac troponin (cTnT) has served us well for more than
a decade as the biochemical benchmark for the diagnosis of
myocardial infarction. During the past years, it has become
clear that cTn elevation also may be seen in many other
conditions affecting cardiomyocyte integrity (e.g., congestive
heart failure, stable coronary artery disease, or atrial ﬁbril-
lation) (1,2). Research on this area has been fueled following
the implementation of high-sensitivity assays that made it
possible to detect circulating cTn levels in community-
dwelling populations. Even in these individuals, cTn
reﬂects the presence of chronic cardiac abnormalities and is
highly predictive for adverse outcome, namely mortality and
heart failure admissions (3,4).See page 1694In this issue of the Journal, Lazzarino et al. (5) present
interesting new data on the implications of cTn in community
dwellers. The authors measured cTnT (cTnT) using a high-
sensitivity assay in 508 men and women without cardiovas-
cular disease. Measurements were performed 75 minutes after
a mental stress test. The authors found a positive association
between the stress level (expressed as the salivary cortisol
increase) and detectable cTnT levels (n ¼ 85 [16.7%]). This
association was signiﬁcant inmultivariable analyses, consistent
following quite extensive adjustment, and seen both in indi-
viduals with and without coronary artery calciﬁcation deﬁned
by the Agatston score.
These ﬁndings are novel in nature and intriguing at the
same time. As always with cross-sectional studies, the word
caution is needed when interpreting the data because it is
difﬁcult to determine the causal sequence between mental
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Laboratories and Fiomi Diagnostics.a multitude of possible pathways and mechanisms, some of
which are given below.
1. There could be a direct impact of cortisol on cardio-
myocytes through increased oxidative stress, modula-
tion of ion channels, or potentiation of adrenergic
signaling. However, the baseline salivary cortisol level
before mental stress exposure was not associated with
detectable cTnT levels, which argues against this
hypothesis.
2. The authors discussed moreover whether cTnT leakage
could have been caused by clinically silent myocardial
necrosis due to the rupture of noncalciﬁed coronary
plaques that remained undetected by the means of
cardiac computed tomography (CT). Although inter-
esting, this hypothesis is highly speculative and needs to
be investigated by other means, preferably coronary
imaging.
3. Mental stress might have caused cTnT leakage directly
via increased sympathomimetic activity, as seen in
Takotsubo cardiomyopathy. Intriguingly, previous
studies seem to support this hypothesis because left
ventricular wall motion abnormalities and regional
perfusion changes have been noted in patients with
coronary artery disease subjected to mental stress (6). If
this translates also to cTn increases, there would be
major consequences on how we measure and interpret
cTn levels in clinical situations. Just think of cTn
measurement under potentially stressful conditions
such as in chest pain patients admitted to a busy
emergency department.
This leads directly to the question whether higher
cTn levels after mental stress would reﬂect a physio-
logical response similarly to cTn increases seen after
physical exercise (7). In other, more provocative
terms: will even ordinary people (or their doctors)
increase in their cTn levels when subjected to daily
hassles in life (e.g., trafﬁc congestion; arguing with
teenagers [6]; working on-call duty; reading new
guidelines on the deﬁnition of myocardial infarction),
and what importance would this have? Unfortu-
nately, due to its design, the study from Lazzarino
et al. (5) does not help us with this question: cTnT
was not measured at baseline (i.e., before mental
stress exposure) why it was not possible to deﬁnitely
determine whether mental stress was the cause of
cTnT increase.
4. However, even the opposite could be true. Hyperre-
sponsiveness to mental stress might identify a pheno-
type that is more prone to develop subclinical
cardiovascular disease, which in turn is reﬂected by
persistently detectable cTnT levels. Of all discussed
hypotheses explaining the ﬁndings in the present study,
this appears to be the most plausible one, as acknowl-
edged by Lazzarino et al. (5), who, however, are
surprisingly vague about clinical implications.
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1703Cardiovascular hyperresponsiveness to mental and emo-
tional stressors has long been regarded to be a potential
contributor to the individual differences in cardiovascular
disease risk. Heightened cardiovascular stress reactivity,
primarily the increase in heart rate and blood pressure, results
in increased oxidation of low-density lipoproteins and higher
serum concentrations of both proinﬂammatory cytokines and
blood insulin, and portends to the development of structural
and functional cardiovascular abnormalities. A large body of
evidence links cardiovascular hyperresponsiveness to objective
outcomes including hypertension, atherosclerosis, left ven-
tricular hypertrophy, and cardiovascular disease mortality.
Comprehensive reviews on this topic are available (6,8).
Mental stress appears thus to provide a milieu of increased
vulnerability to the heart and the vessels. This is acknowl-
edged in current guidelines recommending diverse stress
intervention programs (e.g., cognitive behavioral interven-
tions, relaxation training, or regular physical exercise) (9).
The question, however, is for how long or how aversive
a stressor has to be to lead to impaired cardiac functioning?
The study from Lazzarino et al. (5) provides new evidence in
this regard as it clearly demonstrated that even shorter
episodes of obviously benign stress are associated with
detectable cTnT levels which if persistently raised, need to
be regarded as an indicator of adverse processes affecting the
heart.
The study from Lazzarino et al. (5) is also important
because it emphasizes the notion that cTn not only reﬂects
prevalent cardiac abnormalities but also a risk pattern por-
tending to their development. cTn has, for example, been
shown to be associated with hypertension, smoking, obesity,
hyperlipidemia, diabetes, and lower levels of physical exercise
(3,4,10,11). The study from Lazzarino et al. (5) adds short
episodes of mental stress to this list. Further studies are now
warranted to investigate whether chronic stressors (e.g., low
social support, job stress and exhaustion, racial discrimina-
tion) would also result in similar ﬁndings.
What shall we do about this? Shall we simply recommend
our patients to try not to get stressed? Unfortunately, life is
more complicated than this and all of us will have to cope
with different degrees of stress exposure even in the future.
Still, it is difﬁcult to determine at which level mental stress
turns from healthy to adverse. Nevertheless, we can help ourpatients to cope with negative stress-related effects by
referring them to psychosocial intervention programs - an
important but likely underused treatment option (12).
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